Results 151 to 160 of about 56,967 (294)
ABSTRACT Introduction/Aims Pain is a recognized symptom of muscular dystrophy (MD), but little is known about prescription pain medications in this population. We describe pain experiences and pain medications prescribed for individuals with selected MDs using population‐based surveillance data collected by the Muscular Dystrophy Surveillance, Tracking,
Jonathan Suhl+9 more
wiley +1 more source
Amitriptyline potently neutralizes distinct SARS-CoV-2 variants including D614G, Omicron BA.5, and Omicron XBB.1. [PDF]
Zydek I+13 more
europepmc +1 more source
Blockade of cardiac sodium channels by amitriptyline and diphenylhydantoin. Evidence for two use-dependent binding sites. [PDF]
Michael Barber+2 more
openalex +1 more source
Amitriptyline for neuropathic pain in adults.
R. A. Moore+4 more
semanticscholar +1 more source
Abstract From around 1960 to 2000, Japanese psychiatrists used their own concept of depression (Utsu‐byo うつ病). To distinguish this from major depressive disorder (MDD), the present concept of depression according to the revised version of the Diagnostic and Statistical Manual of Mental Disorders, 5th edition, the present author refers to this concept ...
Susumu Ohmae
wiley +1 more source
Effects of Desipramine, Amitriptyline, and Fluoxetine on Pain in Diabetic Neuropathy [PDF]
Mitchell B. Max+5 more
openalex +1 more source
Embedding Pharmacogenetics Into Clinical Practice to Improve Patient Outcomes
ABSTRACT Pharmacogenomics, the use of germline genomic data to guide prescription to improve effective and safer medication, holds promise as a clinical intervention. To date in most health systems, there has been limited uptake of pharmacogenomic testing confined to a few single drug–gene associations.
John Henry McDermott+3 more
wiley +1 more source
Pooling Two Controlled Comparisons of Milnacipran (F2207) and Amitriptyline in Endogenous Inpatients [PDF]
R. von Frenckell+3 more
openalex +1 more source
ABSTRACT Background and Aims Chronic inflammatory demyelinating polyneuropathy (CIDP) is an immune‐mediated syndrome characterized by progressive muscle weakness and sensory impairment. Clinical similarities with other neuropathies can cause misdiagnoses and delayed diagnoses. Additionally, a large proportion of patients appropriately treated according
Luis Querol+10 more
wiley +1 more source